Voloridge Investment Management
CPRX icon

Voloridge Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Voloridge Investment Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-188,184
Closed -$4.39M – 1059
2025
Q4 		$4.39M Sell
188,184
-60,372
-24% -$1.34M 0.02% 789
2025
Q3 		$4.9M Buy
+248,556
New +$5.11M 0.02% 750
2025
Q2 		– Sell
-112,137
Closed -$2.72M – 1197
2025
Q1 		$2.72M Sell
112,137
-419,699
-79% -$9.45M 0.01% 911
2024
Q4 		$11.1M Sell
531,836
-235,393
-31% -$5.06M 0.04% 540
2024
Q3 		$15.3M Buy
767,229
+12,504
+2% +$232K 0.06% 451
2024
Q2 		$11.7M Sell
754,725
-328,312
-30% -$5.11M 0.04% 528
2024
Q1 		$17.3M Buy
1,083,037
+453,665
+72% +$6.84M 0.06% 365
2023
Q4 		$10.6M Buy
629,372
+229,213
+57% +$3.13M 0.04% 463
2023
Q3 		$4.68M Buy
400,159
+183,820
+85% +$2.46M 0.02% 682
2023
Q2 		$2.91M Sell
216,339
-286,589
-57% -$4.12M 0.01% 867
2023
Q1 		$8.34M Sell
502,928
-3,568
-0.7% -$58.9K 0.04% 505
2022
Q4 		$9.42M Sell
506,496
-210,250
-29% -$3.24M 0.05% 451
2022
Q3 		$9.2M Buy
+716,746
New +$8.49M 0.05% 466
2020
Q2 		– Sell
-128,039
Closed -$493K – 1292
2020
Q1 		$493K Sell
128,039
-156,559
-55% -$643K 0.01% 717
2019
Q4 		$1.07M Buy
284,598
+267,101
+1,527% +$1.25M 0.02% 634
2019
Q3 		$93K Buy
+17,497
New +$93.2K ﹤0.01% 1019

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Voloridge Investment Management's CPRX Position: Q1 2026 in Review

Voloridge Investment Management sold out of Catalyst Pharmaceutical (CPRX) in Q1 2026, closing a stake of 188,184 shares — an estimated $4.39M sold.

Voloridge Investment Management first reported a position in CPRX in Q3 2019 and held it in 16 quarters. The position peaked at $17.3M in Q1 2024. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Voloridge Investment Management reported no remaining Catalyst Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 188,184 Catalyst Pharmaceutical shares in Q1 2026, an estimated $4.39M.
  • Voloridge Investment Management first reported a position in Catalyst Pharmaceutical in Q3 2019 and held it in 16 quarters.
  • Voloridge Investment Management's Catalyst Pharmaceutical position peaked at $17.3M in Q1 2024.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.